Literature DB >> 28501890

The role of adipokines as prognostic factors of one-year mortality in hip fracture patients.

T Gulin1, I Kruljac2, L S Kirigin Biloš2, M Gulin3, M Grgurević4, M Borojević5.   

Abstract

This study investigated the impact of anthropometric parameters, adiponectin, leptin, homeostatic model assessment for insulin resistance (HOMA-IR), beta-isomerised C-terminal telopeptide of collagen type I (β-CTX), and routine biochemical tests on one-year mortality in hip fracture patients. We found that male patients with high adiponectin, leptin, and β-CTX levels had a 5-fold increase in all-cause one-year mortality.
INTRODUCTION: Several predictors of one-year hip fracture mortality have been identified including advanced age, male sex, low bone mineral density, and preexisting comorbidities. However, the impact of metabolic parameters on hip fracture mortality remains unknown. The aim of this study was to examine the effect of serum leptin and adiponectin levels, as well as other metabolic parameters on all-cause one-year hip fracture mortality.
METHODS: This prospective study included 236 patients of all ages with non-traumatic hip fractures. Anthropometric parameters, adiponectin, leptin, HOMA-IR, β-CTX, and routine biochemical tests were recorded at admission and correlated with one-year mortality by using multivariate Cox proportional hazard models.
RESULTS: The median patient age was 82 (75-87) years, and one-year mortality rate was 28.4%. In univariate analysis, adiponectin, age, β-CTX, and renal function were associated with mortality. However, in a multivariate model, male gender, high β-CTX, adiponectin, and leptin were independently associated with increased mortality. Thus, we constructed a nomogram that included all the latter variables in addition to age. The nomogram predicted mortality with a sensitivity of 74.8% (66.0-82.3) and specificity of 74.4% (57.9-87.0), and had an area under the curve of 0.784. Patients that scored <9.2 had a mortality of 10.1%, while those with >9.2 had a mortality of 49.2% (relative risk 5.4, 95% CI 2.8-10.2, P < 0.001).
CONCLUSION: Male patients with high adiponectin, leptin, and β-CTX levels have a 5-fold increase in all-cause one-year mortality after hip fracture.

Entities:  

Keywords:  Adiponectin; hip fracture; leptin; metabolic parameters; one-year mortality; risk factors

Mesh:

Substances:

Year:  2017        PMID: 28501890     DOI: 10.1007/s00198-017-4068-2

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  45 in total

1.  Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure.

Authors:  Caroline Kistorp; Jens Faber; Søren Galatius; Finn Gustafsson; Jan Frystyk; Allan Flyvbjerg; Per Hildebrandt
Journal:  Circulation       Date:  2005-09-12       Impact factor: 29.690

Review 2.  Adiponectin--an adipokine with unique metabolic properties.

Authors:  Andrzej Wiecek; Marcin Adamczak; Jerzy Chudek
Journal:  Nephrol Dial Transplant       Date:  2007-01-18       Impact factor: 5.992

3.  Serum testosterone but not leptin predicts mortality in elderly men.

Authors:  Aapo Lehtonen; Risto Huupponen; Jaakko Tuomilehto; Sirkku Lavonius; Seija Arve; Hannu Isoaho; Ilpo Huhtaniemi; Reijo Tilvis
Journal:  Age Ageing       Date:  2008-03-12       Impact factor: 10.668

4.  Cardiovascular morbidity and mortality associated with the metabolic syndrome.

Authors:  B Isomaa; P Almgren; T Tuomi; B Forsén; K Lahti; M Nissén; M R Taskinen; L Groop
Journal:  Diabetes Care       Date:  2001-04       Impact factor: 19.112

5.  Mortality after hip fracture in diabetic patients.

Authors:  N E Gulcelik; M Bayraktar; O Caglar; M Alpaslan; J Karakaya
Journal:  Exp Clin Endocrinol Diabetes       Date:  2011-05-06       Impact factor: 2.949

6.  Plasma leptin levels are increased in survivors of acute sepsis: associated loss of diurnal rhythm, in cortisol and leptin secretion.

Authors:  S R Bornstein; J Licinio; R Tauchnitz; L Engelmann; A B Negrão; P Gold; G P Chrousos
Journal:  J Clin Endocrinol Metab       Date:  1998-01       Impact factor: 5.958

7.  CDH13 genotype-dependent association of high-molecular weight adiponectin with all-cause mortality: the J-SHIPP study.

Authors:  Eri Uetani; Yasuharu Tabara; Ryuichi Kawamoto; Hiroshi Onuma; Katsuhiko Kohara; Haruhiko Osawa; Tetsuro Miki
Journal:  Diabetes Care       Date:  2013-09-16       Impact factor: 19.112

8.  Leptin, but not adiponectin, is a predictor of recurrent cardiovascular events in men: results from the LIPID study.

Authors:  S Söderberg; D Colquhoun; A Keech; J Yallop; E H Barnes; C Pollicino; J Simes; A M Tonkin; P Nestel
Journal:  Int J Obes (Lond)       Date:  2008-12-09       Impact factor: 5.095

9.  Predictors of early mortality after hip fracture surgery.

Authors:  Muhammad Asim Khan; Fahad Siddique Hossain; Iftikhar Ahmed; Nagarajan Muthukumar; Amr Mohsen
Journal:  Int Orthop       Date:  2013-08-28       Impact factor: 3.075

10.  Mortality and cause of death in hip fracture patients aged 65 or older: a population-based study.

Authors:  Jorma Panula; Harri Pihlajamäki; Ville M Mattila; Pekka Jaatinen; Tero Vahlberg; Pertti Aarnio; Sirkka-Liisa Kivelä
Journal:  BMC Musculoskelet Disord       Date:  2011-05-20       Impact factor: 2.362

View more
  2 in total

1.  The Adiponectin Paradox for All-Cause and Cardiovascular Mortality.

Authors:  Claudia Menzaghi; Vincenzo Trischitta
Journal:  Diabetes       Date:  2018-01       Impact factor: 9.461

2.  Geographic Variations in Intertrochanteric Femoral Fractures in China.

Authors:  Qian-Hao Yang; Yi-Xuan Chen; Dao-Yu Zhu; Zi-Sheng Ai; You-Shui Gao
Journal:  Biomed Res Int       Date:  2019-10-17       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.